This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2023, by business segment. In 2023, the company spent the highest amount within the given period, around 11.4 billion U.S. dollars, for research and development in the brand pharmaceuticals division.
Novartis AG's spending on research and development by segment from 2017 to 2023
(in billion U.S. dollars)
All figures are rounded.
* During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's R&D expenses are not included from this year onwards.
** Due to the spin-off of Sandoz during 2023, there was no distribution of R&D spending by segment. The Innovative Medicines segment is now renamed to "Promoted brands".
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Novartis. (January 31, 2024). Novartis AG's spending on research and development by segment from 2017 to 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/265845/novartis-spending-on-research-and-development-by-division/
Novartis. "Novartis AG's spending on research and development by segment from 2017 to 2023 (in billion U.S. dollars)." Chart. January 31, 2024. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/265845/novartis-spending-on-research-and-development-by-division/
Novartis. (2024). Novartis AG's spending on research and development by segment from 2017 to 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/265845/novartis-spending-on-research-and-development-by-division/
Novartis. "Novartis Ag's Spending on Research and Development by Segment from 2017 to 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 31 Jan 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/265845/novartis-spending-on-research-and-development-by-division/
Novartis, Novartis AG's spending on research and development by segment from 2017 to 2023 (in billion U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/265845/novartis-spending-on-research-and-development-by-division/ (last visited September 20, 2024)
Novartis AG's spending on research and development by segment from 2017 to 2023 (in billion U.S. dollars) [Graph], Novartis, January 31, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/265845/novartis-spending-on-research-and-development-by-division/
